Finance

Lists
4967:TYO
Kobayashi Pharmaceutical Co Ltd
7 153,00 JP¥
+1,76%
(+124,00) 1D
7-окт., 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4967...
Open
7 040 JP¥
High
7 162 JP¥
Low
7 008 JP¥
Mkt. cap
560,92 млд
Avg. vol.
294,95 миң
Volume
310,20 миң
Dividend
1,47%
Quarterly dividend
26 JP¥
Ex-dividend date
2026-ж., 29-дек.
P/E ratio
327,23
52-wk high
7 222 JP¥
52-wk low
5 030 JP¥
EPS
22 JP¥
Shares outstanding
79,07 млн
No. of employees
4 миң
Open
7 040 JP¥
High
7 162 JP¥
Low
7 008 JP¥
Mkt. cap
560,92 млд
Avg. vol.
294,95 миң
Volume
310,20 миң
Dividend
1,47%
Quarterly dividend
26 JP¥
Ex-dividend date
2026-ж., 29-дек.
P/E ratio
327,23
52-wk high
7 222 JP¥
52-wk low
5 030 JP¥
EPS
22 JP¥
Shares outstanding
79,07 млн
No. of employees
4 миң
News stories
From web sources and news partners
About Kobayashi Pharmaceutical Co Ltd
CEOKazumasa Kobayashi
Employees3,73 миң
Founded1919-ж., 22-авг.
Headquarters-
SectorPersonal care products
Last report
2026-ж., 6-авг.
Fiscal period
Q2 2026
- / -
Revenue / Est. (JPY)
37,08 млд / 37,51 млд
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
43,02 млд
53,70 млд
35,38 млд
37,08 млд
Cost of goods sold
20,30 млд
27,85 млд
17,21 млд
18,19 млд
Cost of revenue
20,30 млд
27,85 млд
17,21 млд
18,19 млд
Research and development expenses
-
9,12 млд
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17,87 млд
6,76 млд
17,10 млд
18,08 млд
Operating expense
17,87 млд
22,50 млд
17,10 млд
18,04 млд
Total operating expenses
38,17 млд
50,36 млд
34,31 млд
36,23 млд
Operating income
4,85 млд
3,35 млд
1,06 млд
851,00 млн
Other non operating income
593,00 млн
-150,00 млн
-530,00 млн
20,00 млн
EBT including unusual items
5,02 млд
-5,52 млд
1,11 млд
483,00 млн
EBT excluding unusual items
5,68 млд
4,07 млд
829,50 млн
1,33 млд
Income tax expense
1,37 млд
-2,37 млд
541,00 млн
383,00 млн
Effective tax rate
27,33%
42,97%
48,76%
79,30%
Other operating expenses
-
1,26 млд
-
-
Net income
3,64 млд
-3,15 млд
568,00 млн
100,00 млн
Net profit margin
8,47%
-5,87%
1,61%
0,27%
Earnings per share
-
-
-
-
Interest and investment income
94,00 млн
448,00 млн
295,50 млн
454,00 млн
Interest expense
-3,00 млн
-13,00 млн
-5,00 млн
-6,00 млн
Net interest expenses
91,00 млн
435,00 млн
290,50 млн
448,00 млн
Depreciation and amortization charges
-
3,89 млд
-
-
EBITDA
6,85 млд
5,53 млд
3,45 млд
3,24 млд
Gain or loss from assets sale
-
-
39,50 млн
-
AI content may include mistakes. Learn more
Google колдонмолору